EP2271348
Töflusamsetning af tetrasýklínefnasambandi til notkunar um munn
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.3.2009EP published:
28.3.2018EP application number:
09723896.8
EP translation filed:
7.5.2018Grant published:
15.6.2018EPO information:
European Patent Register
Max expiry date:
29.3.2029Expiry date:
29.3.2027Next due date:
31.3.2027
Title:
ORAL TABLET FORMULATION OF TETRACYCLINE COMPOUND
Timeline
Today
30.3.2009EP application
28.3.2018EP Publication
7.5.2018Translation submitted
15.6.2018Registration published
29.3.2027Expires
Owner
Name:
Paratek Pharmaceuticals, Inc.Address:
75 Park Plaza, 02116, Boston, MA, US
Inventor
Name:
JOHNSTON, SeanAddress:
DoylestownPennsylvania, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
40398 PDate:
28.3.2008Country:
US
Classification
Categories:
A61K 9/20, A61K 31/65, A61K 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 20.7.2018
Expires: 29.3.2019
Payer: Árnason Faktor
Number: 11
Paid: 4.3.2019
Expires: 29.3.2020
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 3.3.2020
Expires: 29.3.2021
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 2.3.2021
Expires: 29.3.2022
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 2.3.2022
Expires: 29.3.2023
Payer: Patice ehf.
Number: 15
Paid: 9.3.2023
Expires: 29.3.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 19.3.2024
Expires: 29.3.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 13.2.2025
Expires: 29.3.2026
Payer: Árnason Faktor ehf.
Number: 18
Paid: 27.3.2026
Expires: 29.3.2027
Payer: Árnason Faktor ehf.